Skip to content

The Effectiveness of Sedation and Analgesia in Colonoscopy Treatment of Colorectal Polyps

The Effectiveness of Sedation and Analgesia in Colonoscopy Treatment of Colorectal Polyps: a Single-center, Prospective, Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04906317
Enrollment
340
Registered
2021-05-28
Start date
2020-12-01
Completion date
2024-12-12
Last updated
2021-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy, Sedation and Analgesia

Brief summary

This study aims to evaluate the effectiveness of sedation and analgesia in the treament of colorectal polyps by colonoscopy.

Detailed description

Colorectal polyps are precancerous lesions of the colorectal cancer. Colonoscopy can reduce the risk of colorectal cancer. Painless endoscopy could reduce patient discomfort and improves the acceptance of treatment, especially for the endoscopic treatment of colorectal polyps. Intravenous anesthesia colonoscopy has a strong sedative effect and has obvious inhibitory effects on the respiratory and circulatory systems. It requires the assistance of an anesthesiologist. The lack of anesthesiologists makes it difficult to make an appointment for anesthesia colonoscopy, which is a bottleneck in the diagnosis and treatment of gastrointestinal diseases in China. Therefore, there is an urgent need to find a painless diagnosis and treatment method that is not inferior to anesthesia colonoscopy in comfort to meet the needs of patients. Comparing to anesthesia colonoscopy, sedative and analgesic colonoscopy have similar sedative and analgesic effects and do not require the assistance of an anesthesiologist. However, there is no relevant evaluation on the effectiveness of sedation and analgesia during the endoscopic treatment of colorectal polyps. Our department has used midazolam combined with dezocine to treat 185 patients with colorectal polyps in these years. Retrospective analysis showed that the sedative and analgesic effect is satisfactory. Therefore, it is necessary to make a single-center randomized parallel group controlled non-inferiority study to directly compare the effectiveness of sedation and analgesia versus intravenous anesthesia in endoscopic treatment of colorectal polyps.

Interventions

DRUGmidazolam and dezocine

Midazolam (0.05 mg/kg) and dezocine(5mg) sedation during colonoscopy, targeted to a painless level

DRUGPropofol

standard propofol (1.5mg/kg) induction during colonoscopy, targeted to a moderate sedation level

Sponsors

Sixth Affiliated Hospital, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Colonoscopy diagnosed as a colorectal polyp, the number of polyps is less than 5, and the size of single polyp is less than 2.0 cm * Age more than 18 years and less than 70 years

Exclusion criteria

* Allergy to propofol, dezocine, midazolam or eggs * ASA class IV, short and tick neck, difficult intubation due to inability to open the mouth widely * Suspected of gastrointestinal perforation, bleeding or obstruction * Acute gastrointestinal infection period * History of abdominal surgery * Patients during pregnancy or lactation

Design outcomes

Primary

MeasureTime frameDescription
The score of visual analogue scoring (VAS)immediately after the procedure of colonoscopyAssess immediately after the completement of colonoscopy

Secondary

MeasureTime frameDescription
Treatment feeDuring the colonoscopy procedureThe fee of treatment refers to the total cost of anesthesia fee, anesthesia/sedation drug fee, intraoperative monitoring fee, endoscopy fee and endoscopic treatment fee

Countries

China

Contacts

Primary ContactJiancong Hu, MD
hujianc@mail.sysu.edu.cn+86 02038476875

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026